Diet-Induced Obesity in Mice Affects the Maternal Gut Microbiota and Immune Response in Mid-Pregnancy
Authors:
- Lieske WekemaLWLieske Wekema
- Sam SchoenmakersSSSam Schoenmakers
- Nicole SchenkelaarsNSNicole Schenkelaars
- Anne LaskewitzALAnne Laskewitz
- Romy H. HuurmanRHRomy H. Huurman
- Lei LiuLLLei Liu
- Lisa WaltersLWLisa Walters
- Hermie J. M. HarmsenHHHermie J. M. Harmsen
- Régine P. M. Steegers-TheunissenRégine P. M. Steegers-Theunissen
- Marijke M. FaasMFMarijke M. Faas
Open Access
- 21 August 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 9076
Abstract
Maternal obesity during pregnancy is associated with adverse pregnancy outcomes. This might be due to undesired obesity-induced changes in the maternal gut microbiota and related changes in the maternal immune adaptations during pregnancy. The current study examines how obesity affects gut microbiota and immunity in pregnant obese and lean mice during mid-pregnancy (gestational day 12 (GD12)). C57BL/6 mice were fed a high-fat diet or low-fat diet from 8 weeks before mating and during pregnancy. At GD12, we analyzed the gut microbiota composition in the feces and immune responses in the intestine (Peyer’s patches, mesenteric lymph nodes) and the peripheral circulation (spleen and peripheral blood). Maternal obesity reduced beneficial bacteria (e.g., Bifidobacterium and Akkermansia) and changed intestinal and peripheral immune responses (e.g., dendritic cells, Th1/Th2/Th17/Treg axis, monocytes). Numerous correlations were found between obesity-associated bacterial genera and intestinal/peripheral immune anomalies. This study shows that maternal obesity impacts the abundance of specific bacterial gut genera as compared to lean mice and deranges maternal intestinal immune responses that subsequently change peripheral maternal immune responses in mid-pregnancy. Our findings underscore the opportunities for early intervention strategies targeting maternal obesity, ideally starting in the periconceptional period, to mitigate these obesity-related pregnancy effects.Keywords
Funding Information
- ZonMw Open Competition 2018 (09120011910046)
This publication has 84 references indexed in Scilit:
- T helper 17 (Th17) cell responses to the gut microbiota in human diseasesBiomedicine & Pharmacotherapy, 2023
- Maternal gut microbiota Bifidobacterium promotes placental morphogenesis, nutrient transport and fetal growth in miceCellular and Molecular Life Sciences, 2022
- Maternal obesity during pregnancy leads to derangements in one-carbon metabolism and the gut microbiota: implications for fetal development and offspring wellbeingAmerican Journal of Obstetrics and Gynecology, 2022
- Pre-gestational vs gestational exposure to maternal obesity differentially programs the offspring in miceDiabetologia, 2014
- Human Genetics Shape the Gut MicrobiomeCell, 2014
- Epithelial IL-22RA1-Mediated Fucosylation Promotes Intestinal Colonization Resistance to an Opportunistic PathogenCell Host & Microbe, 2014
- BifidobacteriumCECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed miceObesity, 2013
- Risk factors and outcomes of maternal obesity and excessive weight gain during pregnancyObesity, 2012
- Host Remodeling of the Gut Microbiome and Metabolic Changes during PregnancyCell, 2012
- Maternal obesity and markers of inflammation in pregnancyCytokine, 2009